Genzyme wins FDA approval for stem cell transplant drug
Genzyme will commercialize Mozobil in the US through a blood and marrow transplant sales force that is part of the company’s transplant and oncology business unit. Genzyme has
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.